Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
Cash And Cash Equivalents
$323.1 Mil (As of Jun. 2013)

Onyx Pharmaceuticals, Inc.'s quarterly cash and cash equivalents increased from Dec. 2012 ($153.2 Mil) to Mar. 2013 ($436.5 Mil) but then declined from Mar. 2013 ($436.5 Mil) to Jun. 2013 ($323.1 Mil).

Onyx Pharmaceuticals, Inc.'s annual cash and cash equivalents declined from Dec. 2010 ($226.3 Mil) to Dec. 2011 ($171.6 Mil) and declined from Dec. 2011 ($171.6 Mil) to Dec. 2012 ($153.2 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

Dec03Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12
BS_CashAndCashEquivalents 55.374.246.194.4161.7235.2107.7226.3171.6153.2

Onyx Pharmaceuticals, Inc. Quarterly Data

Mar11Jun11Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13
BS_CashAndCashEquivalents 211.2168.7219.4171.6133.0206.2229.3153.2436.5323.1
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide